Skip to content
News · safety

FDA's 7 GLP-1 Telehealth Red Flags, Checked Against 37 Programs (October 2026)

FDA lists seven warning signs for buying GLP-1 drugs online. We sorted them by when you can check them, then read 37 programs' own pages on October 15, 2026.

Released: Last reviewed:

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 20, 2026 · This page is informational and does not constitute medical advice.
Direct answer · October 15, 2026

FDA's GLP-1 page, current as of October 1, 2026, lists seven telehealth red flags, and four can be checked before you pay. On the 37 program websites we read on October 15, 2026, we found no claim that a compounded drug equals an FDA-approved one, and 32 stated that a licensed clinician reviews you before prescribing.

A page that states a policy is not proof the policy is followed, and three of the seven red flags can only be checked once the package arrives.

What are FDA's seven telehealth red flags for GLP-1 drugs?

FDA's page "FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss" (current as of October 1, 2026) tells you to watch for a company that:

  1. claims the compounded drug is the same as an FDA-approved drug;
  2. offers deep discounts or prices that seem too good to be true;
  3. sends medicine that looks different from before or from the website, or arrives damaged or without instructions;
  4. does not require screening and a prescription by a licensed doctor;
  5. has no licensed doctor to answer questions after delivery;
  6. has spelling errors or a wrong pharmacy address on the label;
  7. puts a pharmacy name on the label you think might be fraudulent.

Which red flags can you check before you pay?

Four: numbers 1, 2, 4 and 5, all readable on the program's own pages.

  • Sameness claims. Compounded semaglutide and tirzepatide are not FDA-approved. They may be made with the drug in Wegovy or Zepbound, but are not the same product.
  • Too-good prices. Compare with the market (below) and read what month two costs.
  • Screening. Look for a sentence saying a licensed clinician reviews your history before prescribing.
  • A doctor afterward. Look for how and when you reach a clinician later.

Which red flags only show up after delivery?

Numbers 3, 6 and 7 need the box in your hands: check the vial's look, intact packaging, instructions, label spelling, and the pharmacy name and address.

FDA knows of fraudulent compounded semaglutide and tirzepatide whose labels name pharmacies that do not exist, or a real licensed pharmacy that did not make the product. FDA also says not to use an injectable GLP-1 that arrives warm or with too little refrigeration. See our shipping guide.

How do the programs we read measure up?

We read 37 programs' own websites on October 15, 2026:

  • Sameness claims: none found. Mondae's page, for one, says its medicines are not generic versions of any FDA-approved medication.
  • Prescribing after clinician review: stated on 32, unclear on 1, not found on 4.
  • Clinician available after delivery: stated on 23, unclear on 8, not found on 6.
  • "Not FDA-approved" statement: present on 30, not found on 7.
FDA before-you-pay checks as printed on each program's own website, read October 15, 2026. Yes = the page said it; Unclear = it mentioned a review or visit but not this point; — = not found on the page read.
ProgramSameness claimRx after clinician reviewClinician after deliveryPharmacy named"Not FDA-approved" noteBasisSource · read date
NexLifeNoYesYesYesYesWebpagenexlife.us, 10/15/2026
AgelessNoYesYesNoYesWebpagetryageless.com, 10/15/2026
CalibrateNo—YesNo—Webpagejoincalibrate.com, 10/15/2026
CollectiveNoYesUnclearNo—Webpagecollective.org, 10/15/2026
CoreAge RxNoYesUnclearNo—Webpagecoreagerx.com, 10/15/2026
CurexNoYesYesNoYesWebpagegetcurex.com, 10/15/2026
EdenNoYesYesYesYesWebpageeden.health, 10/15/2026
EmbodyNoYes—YesYesWebpagejoinem.co, 10/15/2026
Fella Health (sign-ups paused)No——No—Webpagefellahealth.com, 10/15/2026
Fifty410NoYesYesNoYesWebpagefifty410.com, 10/15/2026
FoundNoYesYesNoYesWebpagejoinfound.com, 10/15/2026
FridaysNoYesYesNoYesWebpagejoinfridays.com, 10/15/2026
GobyMedsNo——No—Webpagegobymeds.com, 10/15/2026
HealthRxNoYesYesNoYesWebpagehealthrx.com, 10/15/2026
Henry MedsNoYesUnclearNoYesWebpagehenrymeds.com, 10/15/2026
Ivím HealthNoYesUnclearNoYesWebpageivimhealth.com, 10/15/2026
Lavender Sky HealthNoUnclearYesYesYesWebpagelavenderskyhealth.com, 10/15/2026
LifeMDNo—YesNoYesWebpagelifemd.com, 10/15/2026
Mochi HealthNoYesUnclearNoYesWebpagejoinmochi.com, 10/15/2026
MondaeNoYesYesNoYesWebpagemondae.com, 10/15/2026
MyStart HealthNoYesYesNoYesWebpagemystarthealth.com, 10/15/2026
OrderlyMedsNoYesYesNoYesWebpageorderlymeds.com, 10/15/2026
Ozari HealthNoYesYesNoYesWebpageozarihealth.com, 10/15/2026
Peak WellnessNoYesYesYesYesWebpagego.trypeak.com, 10/15/2026
RaelivaNoYesYesNoYesWebpageonlinesemaglutide.org, 10/15/2026
ReflexMD (partial read)NoYes—No—Webpagereflexmd.com, 10/15/2026
Remedy MedsNoYesYesNo—Webpageremedymeds.com, 10/15/2026
ShedNoYesYesNoYesWebpagetryshed.com, 10/15/2026
SnagRxNoYesUnclearYesYesWebpagesnagrx.com, 10/15/2026
Sprout HealthNoYes—NoYesWebpagejoinsprouthealth.com, 10/15/2026
Strut HealthNoYesUnclearNoYesWebpagestruthealth.com, 10/15/2026
SunlightNoYesYesYesYesWebpagesunlight.com, 10/15/2026
TelePepNoYes—NoYesWebpagetelepeptide.org, 10/15/2026
TelosRxNoYesUnclearYesYesWebpagetelosrx.com, 10/15/2026
WellMedrNoYesYesYesYesWebpagewellmedr.com, 10/15/2026
WillowNoYesYesNoYesWebpagestartwillow.com, 10/15/2026
Zappy HealthNoYesYesYesYesWebpagezappyhealth.com, 10/15/2026

"—" may mean the text is on a page we did not read, so ask in writing. HealthRx's FAQ says "same active molecule" but also "not the same product"; we did not count that as a sameness claim. Pharmacy disclosure has its own page.

We could not read TrimRx, Noom Med, bmiMD, Yucca Health, Hims and Ro on October 15, 2026 (pages failed to load or blocked reads); they are not in the table.

Is a $49 GLP-1 price a red flag?

Not on its own; it is a reason to read the terms. In our price index for October 15, 2026, the lowest printed compounded semaglutide price was $49 a month (WellMedr's sale and NextMeds' "starting at" price, term not printed). The median standing month-to-month price, with no sale, membership or prepayment, was $190 across 15 programs; the lowest standing price was $87 (Mondae).

For tirzepatide, the lowest all-in figure was about $86 (Collective's $69 plus a $199 yearly membership), against a standing median of $299 across 19 programs and a lowest standing rate of $126 (Mondae). The lowest prices came with a sale, prepaid term, membership or unprinted term.

What else does FDA's page warn about?

  • Multi-dose vials: discard within 28 days of first use, even if medicine remains and the compounder says it lasts longer. Use a new sterile needle and syringe every dose.
  • Salt forms: semaglutide sodium and acetate are different active ingredients; FDA knows of no lawful basis to compound with them.
  • Adverse events: as of May 31, 2026, FDA had 990 reports for compounded semaglutide and more than 730 for compounded tirzepatide (likely undercounted, FDA says).

FDA also posted warning letters 737806 and 737810 (dated September 23 and 24, 2026; posted October 6) to websites selling unapproved injectable semaglutide, and letter 738238 to Empower Pharmacy (dated September 18; posted September 22). Our regulatory timeline covers them.

What this means for you

The 28-day rule. Weekly doses on days 1, 8, 15 and 22 fit; a fifth would land on day 29, at the limit. Plan on four doses per vial. If a vial holds eight weekly doses, about half is discarded: 8 − 4 = 4. Ask the vial size first.

The $49 versus $190 gap. $190 − $49 = $141 a month, or $141 × 12 = $1,692 a year ($2,280 versus $588). If $49 covered only month one and the plan then billed $199, the month-to-month rate WellMedr prints: $49 + (11 × $199) = $2,238. Ask what month two costs.

Ask in writing before checkout: who prescribes, how you reach a clinician after delivery and when, and which pharmacy's name will be on the label. On arrival: check the cold pack, packaging, instructions and label before the first dose. See our legitimate-provider checklist and what happens after you pay.

How do you report a problem to FDA?

Use FDA's MedWatch program: report online or fax the form to 1-800-FDA-0178. For label or instruction questions, FDA says to contact the compounder or the telehealth platform.

Red flags are not only clinical: our privacy-policy review checks what 16 programs say about sharing your data.

Frequently asked questions

What are the FDA's telehealth red flags for GLP-1 drugs?

FDA lists seven: claims a compounded drug is the same as an FDA-approved one; prices that seem too good to be true; medicine that looks different, arrives damaged or lacks instructions; no licensed screening and prescription; no licensed doctor after delivery; label spelling errors or wrong pharmacy addresses; and a pharmacy name you suspect is fraudulent.

Which red flags can I check before I pay?

Four: whether the site claims its compounded drug is the same as an FDA-approved drug, whether the price is far below the market, whether a licensed clinician screens you before prescribing, and whether a clinician is available after delivery. Read the program's pages or ask in writing before checkout.

Is a cheap compounded GLP-1 price a red flag?

Not by itself; it is a reason to read the terms. On October 15, 2026 the lowest printed compounded semaglutide price was $49, against a $190 median standing month-to-month price. The lowest prices usually needed a sale, prepaid term or membership, so check what month two costs.

How long can I use a compounded GLP-1 multi-dose vial?

FDA recommends discarding a multi-dose vial within 28 days after first use, even if medicine is left and even if the compounder's instructions allow longer. On a weekly schedule that is about four doses per vial. Use a new sterile needle and syringe for every dose.

How do I report a problem with a compounded GLP-1 to FDA?

Use FDA's MedWatch program: report online, or download the form and fax it to 1-800-FDA-0178. FDA's CDER Office of Drug Information is at druginfo@fda.hhs.gov or 855-543-3784. FDA wants reports of side effects and quality problems, including warm deliveries, and says label or instruction questions should go to the compounder or the telehealth platform.

Sources

  1. FDA. Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. Current as of October 1, 2026; read October 15, 2026.
  2. FDA. MedWatch Adverse Event Reporting Program. Read October 15, 2026.
  3. FDA. Warning letters 737806, 737810 (posted October 6, 2026) and 738238 (posted September 22, 2026).
  4. FDA. BeSafeRx, buying medicines online. Read October 15, 2026.
  5. NexLife tirzepatide plans page. Read October 15, 2026.
  6. Eden GLP-1 weight-loss page. Read October 15, 2026.
  7. Mondae compounded tirzepatide page. Read October 15, 2026.
  8. WellMedr weight-loss page. Read October 15, 2026.

Program checks are first-party reads of each program's own site on October 15, 2026. Quotes are paraphrased where possible.